or Try an Advanced Search...

    Treatment Of Acute Myeloid Leukemia Stocks List

    Symbol Grade Name % Change
    SLS C SELLAS Life Sciences Group, Inc. -0.68
    CGEM C Cullinan Management, Inc. -2.69
    FBIO D Fortress Biotech, Inc. 9.66
    PYXS D Pyxis Oncology, Inc. -0.48
    HCWB F HCW Biologics Inc. 0.00
    BLRX F BioLineRx Ltd. -0.30
    TCBP F TC BioPharm (Holdings) plc -0.88
    APTO F Aptose Biosciences, Inc. -0.84
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Acute Myeloid Leukemia Clinical Medicine Biopharmaceutical Cancer Medicine Solid Tumors Biotechnology Immunotherapy Cancer Treatment Immune System Immunology Immunotherapies Oncology Antineoplastic Drugs Autoimmune Disease Cancer Immunotherapy Cell Therapy Clinical Development Hematologic Malignancies Monoclonal Antibody

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Acute Myeloid Leukemia stocks.

    Symbol Grade Name Weight
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.52
    CNCR D Loncar Cancer Immunotherapy ETF 2.1
    FDM A First Trust DJ Select MicroCap ETF 1.44
    XBI C SPDR S&P Biotech ETF 0.32
    BTEC C Principal Healthcare Innovators Index ETF 0.29
    View all Treatment Of Acute Myeloid Leukemia ETFs...
    Compare ETFs
    Compare BBC to CNCR Compare BBC to FDM Compare XBI to BTEC

        Treatment Of Acute Myeloid Leukemia Stocks Recent News

        Date Stock Title
        May 17 FBIO Fortress Biotech files for $50M mixed shelf
        May 17 BLRX BioLineRx receives Nasdaq minimum bid price notification
        May 17 BLRX BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
        May 16 CGEM Cullinan Therapeutics files to sell 14.4M shares of common stock for holders
        May 16 CGEM Cullinan Therapeutics reports Q1 results
        May 16 FBIO Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
        May 16 FBIO Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
        May 15 FBIO Fortress Biotech GAAP EPS of -$1.03 beats by $0.70, revenue of $13M misses by $1.13M
        May 15 HCWB HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
        May 15 FBIO Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
        May 15 CGEM Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
        May 15 FBIO Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
        May 15 FBIO AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
        May 15 TCBP TCBP Announces Launch of Compassionate Use Program for TCB008
        May 15 FBIO Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
        May 15 APTO Aptose Biosciences Inc. (APTO) Q1 2024 Earnings Call Transcript
        May 14 SLS SELLAS Life Sciences GAAP EPS of -$0.21
        May 14 APTO Aptose Biosciences GAAP EPS of -$0.73 beats by $0.09
        May 14 APTO Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses
        May 14 SLS SELLAS Life Sciences Reports First Quarter 2024 Financial Results and Provides Corporate Update
        Related Industries: Biotechnology
        Related Stock Lists: Acute Myeloid Leukemia Clinical Medicine Biopharmaceutical Cancer Medicine Solid Tumors Biotechnology Immunotherapy Cancer Treatment Immune System Immunology Immunotherapies Oncology Antineoplastic Drugs Autoimmune Disease Cancer Immunotherapy Cell Therapy Clinical Development Hematologic Malignancies Monoclonal Antibody
        Treatment Of Acute Myeloid Leukemia

        Acute myeloid leukemia (AML) is a type of cancer that affects the blood and bone marrow. Treatment for AML typically involves chemotherapy, radiation therapy, and/or stem cell transplantation. Depending on the type of AML, other treatments such as targeted therapy, immunotherapy, and/or clinical trials may also be recommended.

        Browse All Tags